Institutional investors purchased a net $4.0 million shares of OXGN during the quarter ended March 2015, and now own 24.53% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
INTEGRATED WEALTH MANAGEMENT, IN... Bought 333.00 shares of OXiGENE Inc